CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 233 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $248,335 | +96528.4% | 14,978 | +8.5% | 0.00% | 0.0% |
Q4 2022 | $257 | -99.8% | 13,803 | +37.8% | 0.00% | +100.0% |
Q3 2022 | $129,000 | +10.3% | 10,020 | -40.1% | 0.00% | 0.0% |
Q2 2022 | $117,000 | -11.4% | 16,716 | +5.4% | 0.00% | 0.0% |
Q1 2022 | $132,000 | -8.3% | 15,864 | -25.3% | 0.00% | 0.0% |
Q4 2021 | $144,000 | +15.2% | 21,235 | -9.9% | 0.00% | 0.0% |
Q3 2021 | $125,000 | +25.0% | 23,580 | +35.0% | 0.00% | +100.0% |
Q2 2021 | $100,000 | -22.5% | 17,466 | -37.5% | 0.00% | -50.0% |
Q1 2021 | $129,000 | -79.6% | 27,963 | -85.2% | 0.00% | -71.4% |
Q4 2020 | $631,000 | +71.0% | 188,936 | +52.1% | 0.01% | +40.0% |
Q3 2020 | $369,000 | -36.9% | 124,201 | -2.0% | 0.01% | -37.5% |
Q2 2020 | $585,000 | – | 126,674 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANAKA CAPITAL MANAGEMENT INC | 213,609 | $1,446,000 | 2.75% |
GABLES CAPITAL MANAGEMENT INC. | 449,164 | $3,041,000 | 1.81% |
Prairiewood Capital, LLC | 261,403 | $1,770,000 | 1.40% |
ARMISTICE CAPITAL, LLC | 9,572,000 | $64,802,000 | 1.06% |
Quantedge Capital Pte Ltd | 360,100 | $2,438,000 | 1.03% |
SummerHaven Investment Management, LLC | 151,384 | $1,025,000 | 0.55% |
GLOBEFLEX CAPITAL L P | 609,030 | $4,124,000 | 0.42% |
EAM Global Investors LLC | 347,899 | $2,355,000 | 0.42% |
Lanham O'Dell & Company, Inc. | 50,000 | $339,000 | 0.27% |
EAM Investors, LLC | 239,071 | $1,619,000 | 0.27% |